Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial

BACKGROUND AND AIMS: Proctitis is the least extensive type of ulcerative colitis, for which rectal therapy is rarely studied and is underused. This study evaluated the efficacy, safety, and patient’s preference of a novel formulation of budesonide suppository 4 mg, compared with a commercially avail...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruis, Wolfgang, Siegmund, Britta, Lesniakowski, Konrad, Simanenkov, Vladimir, Khimion, Ludmila, Sobon, Marcin, Delmans, Glebs, Maksyashina, Svetlana V, Sablin, Oleg A, Pokrotnieks, Juris, Mostovoy, Yuriy, Datsenko, Olena, Abdulkhakov, Sayar, Dorofeyev, Andriy, Levchenko, Olena, Alexeeva, Olga, Andreev, Pavel, Kolesnik, Ivan P, Mihaly, Emese, Abrahamovych, Orest, Baluta, Malgorzata, Kharchenko, Nataliia, Viacheslav, Neshta, Uspenskiy, Yury, Vieth, Michael, Mohrbacher, Ralf, Mueller, Ralph, Greinwald, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683080/
https://www.ncbi.nlm.nih.gov/pubmed/35709376
http://dx.doi.org/10.1093/ecco-jcc/jjac081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683080/
https://www.ncbi.nlm.nih.gov/pubmed/35709376
http://dx.doi.org/10.1093/ecco-jcc/jjac081

Ejemplares similares